相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Charles L. Daley et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
Matt Shirley
DRUGS (2019)
Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
Nakwon Kwak et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
Jakko van Ingen et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
Jimin Zhang et al.
FRONTIERS IN MICROBIOLOGY (2018)
Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
Davide Caimmi et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT)
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence
Jotam G. Pasipanodya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Randomized Trial of Liposomal Amikacin for Inhlation in Nontuberculous Mycobacterial Lung Disease
Kenneth N. Olivier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
R. Andres Floto et al.
THORAX (2016)
分享论文
